[1]胡欣,褚晓秋,陈国芳,等.欧洲甲状腺学会/欧洲心血管介入放射学会《甲状腺癌微创治疗的临床实践指南》解读:审时与度势[J].国际内分泌代谢杂志,2023,43(03):278-282.[doi:10.3760/cma.j.cn121383-20211126-11069]
 Hu Xin,Chu Xiaoqiu,Chen Guofang,et al.[J].International Journal of Endocrinology and Metabolism,2023,43(03):278-282.[doi:10.3760/cma.j.cn121383-20211126-11069]
点击复制

欧洲甲状腺学会/欧洲心血管介入放射学会《甲状腺癌微创治疗的临床实践指南》解读:审时与度势()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
43
期数:
2023年03期
页码:
278-282
栏目:
指南与共识
出版日期:
2023-05-20

文章信息/Info

作者:
胡欣褚晓秋陈国芳徐书杭刘超
南京中医药大学附属中西医结合医院内分泌科,南京 210028
Author(s):
Hu Xin Chu Xiaoqiu Chen Guofang Xu Shuhang Liu Chao
Department of Endocrinology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
关键词:
甲状腺癌 甲状腺微小乳头状癌 复发性甲状腺癌 甲状腺癌远处转移 微创治疗
Keywords:
Thyroid cancer Papillary thyroid microcarcinomas Recurrent thyroid carcinoma Metastastic thyroid cancer Minimally invasive treatment
DOI:
10.3760/cma.j.cn121383-20211126-11069
摘要:
甲状腺癌的微创治疗现状仍颇具争议。欧洲甲状腺学会/欧洲心血管介入放射学会于2021年发布了《甲状腺癌微创治疗的临床实践指南》,其纳入了甲状腺癌微创治疗的新近研究结果,界定了甲状腺癌微创治疗及综合治疗的适应证,并对原发性甲状腺癌、复发性甲状腺癌及甲状腺癌远处转移的微创治疗进行了详细阐述。本指南共有18条推荐条款,涵盖了微创治疗的指征评估、治疗模式的选择、微创治疗的利弊与随访监测等方面,为甲状腺癌的微创治疗提供了更为合理及规范的建议。
Abstract:
The status of minimally invasive treatment for thyroid cancer remains controversial. European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe issued clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions in 2021, which incorporated recent findings on minimally invasive treatment of thyroid carcinoma, and the indications for minimally invasive treatment or a multimodality approach of thyroid malignancies were defined. The minimally invasive treatment in primary thyroid neoplasms, neck recurrences of thyroid carcinoma, and metastastic thyroid cancer were clarified. This guideline consists of 18 recommendations, covering the scopes of assessment of the indications, preference of treatment modalities, advantages and limitations of minimally invasive treatment, and follow-up, which provide more reasonable and standardized guidance for minimally invasive treatment of thyroid cancer.

参考文献/References:

[1] Siegel RL,Miller KD,Fuchs HE,et al.Cancer statistics,2021[J].CA Cancer J Clin,2021,71(1):7-33.DOI:10.3322/caac.21654.
[2] Lim H,Devesa SS,Sosa JA,et al.Trends in thyroid cancer incidence and mortality in the United States,1974-2013[J].JAMA,2017,317(13):1338-1348.DOI:10.1001/jama.2017.2719.
[3] Mauri G,Hegedüs L,Bandula S,et al.European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions[J].Eur Thyroid J,2021,10(3):185-197.DOI:10.1159/000516469.
[4] Cho SJ,Baek JH,Chung SR,et al.Thermal ablation for small papillary thyroid cancer:a systematic review[J].Thyroid,2019,29(12):1774-1783.DOI:10.1089/thy.2019.0377.
[5] Choi Y,Jung SL.Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma:a systematic review and meta-analysis[J].Thyroid,2020,30(5):720-731.DOI:10.1089/thy.2019.0707.
[6] Tong M,Li S,Li Y,et al.Efficacy and safety of radiofrequency,microwave and laser ablation for treating papillary thyroid microcarcinoma:a systematic review and meta-analysis[J].Int J Hyperthermia,2019,36(1):1278-1286.DOI:10.1080/02656736.2019.1700559.
[7] Cho SJ,Baek SM,Na DG,et al. Five-year follow-up results of thermal ablation for low-risk papillary thyroid microcarcinomas:systematic review and meta-analysis[J].Eur Radiol,2021,31(9):6446-6456.DOI:10.1007/s00330-021-07808-x.
[8] Mauri G,Orsi F,Carriero S,et al.Image-guided thermal ablation as an alternative to surgery for papillary thyroid microcarcinoma:preliminary results of an Italian experience[J].Front Endocrinol(Lausanne),2021,11:575152.DOI:10.3389/fendo.2020.575152.
[9] Orloff LA,Noel JE,Stack BC Jr,et al. Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease:An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery,Associazione Medici Endocrinologi,British Association of Endocrine and Thyroid Surgeons,European Thyroid Association,Italian Society of Endocrine Surgery Units,Korean Society of Thyroid Radiology,Latin American Thyroid Society,and Thyroid Nodules Therapies Association[J].Head Neck,2022,44(3):633-660.DOI:10.1002/hed.26960.
[10] Park KW,Shin JH,Han BK,et al.Inoperable symptomatic recurrent thyroid cancers:preliminary result of radiofrequency ablation[J].Ann Surg Oncol,2011,18(9):2564-2568.DOI:10.1245/s10434-011-1619-1.
[11] Chung SR,Baek JH,Choi YJ,et al.Efficacy of radiofrequency ablation for recurrent thyroid cancer invading the airways[J].Eur Radiol,2021,31(4):2153-2160.DOI:10.1007/s00330-020-07283-w.
[12] Ha SM,Sung JY,Baek JH,et al.Radiofrequency ablation of small follicular neoplasms:initial clinical outcomes[J].Int J Hyperthermia,2017,33(8):931-937.DOI:10.1080/02656736.2017.1331268.
[13] Dobrinja C,Bernardi S,Fabris B,et al.Surgical and pathological changes after radiofrequency ablation of thyroid nodules[J].Int J Endocrinol,2015,2015:576576.DOI:10.1155/2015/576576.
[14] Heilo A,Sigstad E,Fagerlid KH,et al.Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastaticcervical lymph nodes from papillary thyroid carcinoma[J].J Clin Endocrinol Metab,2011,96(9):2750-2755.DOI:10.1210/jc.2010-2952.
[15] Guenette JP,Monchik JM,Dupuy DE.Image-guided ablation of postsurgical locoregional recurrence of biopsy-proven well-differentiated thyroid carcinoma[J].J Vasc Interv Radiol,2013,24(5):672-679.DOI:10.1016/j.jvir.2013.02.001.
[16] Hahn SY,Shin JH,Na DG,et al.Ethanol ablation of the thyroid nodules:2018 consensus statement by the Korean Society of Thyroid Radiology[J].Korean J Radiol,2019,20(4):609-620.DOI:10.3348/kjr.2018.0696.
[17] Zhao Q,Tian G,Kong D,et al.Meta-analysis of radiofrequency ablation for treating the local recurrence of thyroid cancers[J].J Endocrinol Invest,2016,39(8):909-916.DOI:10.1007/s40618-016-0450-8.
[18] Papini E,Bizzarri G,Bianchini A,et al.Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer[J].J Clin Endocrinol Metab,2013,98(1):E92-97.DOI:10.1210/jc.2012-2991.
[19] Mauri G,Cova L,Ierace T,et al.Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation[J].Cardiovasc Intervent Radiol,2016,39(7):1023-1030.DOI:10.1007/s00270-016-1313-6.
[20] Han ZY,Dou JP,Cheng ZG,et al.Efficacy and safety of percutaneous ultrasound-guided microwave ablation for cervical metastatic lymph nodes from papillary thyroid carcinoma[J].Int J Hyperthermia,2020,37(1):971-975.DOI:10.1080/02656736.2020.1805128.

相似文献/References:

[1]于亚静 杨彩哲 关小宏 王良宸 吴石白 刘明 肖黎 张妲 刘朝阳.甲状腺癌与桥本甲状腺炎及其他相关危险因素的研究[J].国际内分泌代谢杂志,2015,(01):27.[doi:10.3760/cma.j.issn.1673-4157.2015.01.006]
 Yu Yajing*,Yang Caizhe,Guan Xiaohong,et al.Relationship between thyroid carcinoma, Hashimoto′s thyroiditis and other related risk factors[J].International Journal of Endocrinology and Metabolism,2015,(03):27.[doi:10.3760/cma.j.issn.1673-4157.2015.01.006]
[2]李兴佳 曹萌 刘超.自噬与甲状腺癌的关系[J].国际内分泌代谢杂志,2015,(01):56.[doi:10.3760/cma.j.issn.1673-4157.2015.01.014]
 Li Xingjia,Cao Meng,Liu Chao..Relationship between autophagy and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2015,(03):56.[doi:10.3760/cma.j.issn.1673-4157.2015.01.014]
[3]杨成会,缪珩.二甲双胍在甲状腺疾病治疗中的作用[J].国际内分泌代谢杂志,2015,(04):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
 Yang Chenghui,Miao Heng..Roles of metformin in the treatment of thyroid diseases[J].International Journal of Endocrinology and Metabolism,2015,(03):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
[4]孟祥慧,徐书杭,蔡可英,等.肥胖与甲状腺癌:临床新启示[J].国际内分泌代谢杂志,2014,(02):87.[doi:10.3760/cma.j.issn.1673-4157.2014.02.005]
 Meng Xianghui*,Xu Shuhang,Cai Keying,et al.Obesity and thyroid cancer: a new clinical implication[J].International Journal of Endocrinology and Metabolism,2014,(03):87.[doi:10.3760/cma.j.issn.1673-4157.2014.02.005]
[5]孙洪平,陈国芳,曹雯,等.糖尿病与甲状腺癌关系的研究进展[J].国际内分泌代谢杂志,2014,(02):90.[doi:10.3760/cma.j.issn.1673-4157.2014.02.006]
 Sun Hongping,Chen Guofang,Cao Wen,et al.Diabetes and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2014,(03):90.[doi:10.3760/cma.j.issn.1673-4157.2014.02.006]
[6]于亚静,杨彩哲,关小宏,等.桥本甲状腺炎和甲状腺癌的关系[J].国际内分泌代谢杂志,2014,(03):200.[doi:10.3760/cma.j.issn.1673-4157.2014.03.016]
 Yu Yajing,Yang Caizhe,Guan Xiaohong,et al.Relationship between Hashimoto's thyroiditis and thyroid carcinoma[J].International Journal of Endocrinology and Metabolism,2014,(03):200.[doi:10.3760/cma.j.issn.1673-4157.2014.03.016]
[7]张倍宁 闫如意 周金莲 崔彦.甲状腺癌中miRNA的表达及作用[J].国际内分泌代谢杂志,2018,38(03):167.[doi:10.3760/cma.j.issn.1673-4157.2018.03.006]
 Zhang Beining*,Yan Ruyi,Zhou Jinlian,et al.Expression and function of miRNA in thyroid carcinoma[J].International Journal of Endocrinology and Metabolism,2018,38(03):167.[doi:10.3760/cma.j.issn.1673-4157.2018.03.006]
[8]陈茉 徐书杭 刘超.甲状腺微小癌的热消融治疗[J].国际内分泌代谢杂志,2019,39(06):405.[doi:10.3760/cma.j.issn.1673-4157.2019.06.011]
 Chen Mo,Xu Shuhang,Liu Chao.Thermal ablation of thyroid microcarcinoma[J].International Journal of Endocrinology and Metabolism,2019,39(03):405.[doi:10.3760/cma.j.issn.1673-4157.2019.06.011]
[9]任秀利 柳艳萍 宋富军 王亭 倪明 张平平 刘明法.1990—2015年天津市滨海新区甲状腺癌 流行特征及长期发病趋势分析[J].国际内分泌代谢杂志,2020,40(02):73.[doi:10.3760/cma.j.issn.1673-4157.2020.02.001]
 Ren Xiuli,Liu Yanping,Song Fujun,et al.Epidemiological characteristics and long-term trends of thyroid cancer in Binhai New Area of Tianjin from 1990 to 2015[J].International Journal of Endocrinology and Metabolism,2020,40(03):73.[doi:10.3760/cma.j.issn.1673-4157.2020.02.001]
[10]井超,王旭东.免疫治疗在甲状腺癌中的研究进展[J].国际内分泌代谢杂志,2021,41(05):459.[doi:10.3760/cma.j.cn121383-20210624-06069]
 Jing Chao,Wang Xudong..Research progress of immunotherapy in thyroid cancer[J].International Journal of Endocrinology and Metabolism,2021,41(03):459.[doi:10.3760/cma.j.cn121383-20210624-06069]

备注/Memo

备注/Memo:
通信作者:刘超,Email: liuchao@nfmcn.com
基金项目:江苏省重点研发计划(社会发展)(BE2020726)
更新日期/Last Update: 2023-05-20